Cancer-related inflammation
Open accessThe DOI matches its Crossref record; 174 of the 175 references it cites were found in a registry or an index.
Abstract
The mediators and cellular effectors of inflammation are important constituents of the local environment of tumours. In some types of cancer, inflammatory conditions are present before a malignant change occurs. Conversely, in other types of cancer, an oncogenic change induces an inflammatory microenvironment that promotes the development of tumours. Regardless of its origin, 'smouldering' inflammation in the tumour microenvironment has many tumour-promoting effects. It aids in the proliferation and survival of malignant cells, promotes angiogenesis and metastasis, subverts adaptive immune responses, and alters responses to hormones and chemotherapeutic agents. The molecular pathways of this cancer-related inflammation are now being unravelled, resulting in the identification of new target molecules that could lead to improved diagnosis and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“many of these processes also occur in cancer as most of them are inflammation-related, including hypoxia-induced neovascularization, endothelial dysfunction, permeability of the microvasculature and the upregulation of adhesion molecules to facilitate the recruitment of cells30,31.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the other hand, cytokine production can be triggered by oncogenic transformation, metabolic alteration, cell death, hypoxia, and the use of anti-cancer drugs (10).”
From Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis (2021) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides promoting cell proliferation, the action of cytokines in promoting cancer development includes antagonizing anti-tumor immune response, recruiting tumor-supportive stromal cells and immune-suppressive cells, inducing angiogenesis and metastasis, and altering the responses to therapeutic agents (10, 15)”
From Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis (2021) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Excessive or dysregulated inflammation is a major driver of tissue damage and the pathogenesis of numerous diseases, including stroke, Parkinson’s disease, atherosclerosis, and cancer [9,30,31,32,33].”
From Picroside II as a Potential Anti-Inflammatory Agent (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, rather than the dogma that oncogenesis is intrinsically triggered in pre-neoplastic cells, environmental factors, such as infection, stress, obesity, aging and smoking, each of which can induce chronic inflammation, could be a major cause of oncogenesis (4, 6, 9, 233).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [6]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746 · cited 1×
“jpg" NDATA ITEM> ]> Links between cancer and inflammation were first made in the nineteenth century, on the basis of observations that tumours often arose at sites of chronic inflammation and that inflammatory cells were present in biopsied samples from tumour”
Self-citationMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“TAMs and related cell types in mouse and human tumours generally have an M2 phenotype, which is oriented towards promoting tumour growth, remodelling tissues, promoting angiogenesis and suppressing adaptive immunity&hairsp”
Self-citationInvolvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 1×
“This type of response might also contribute to successful chemotherapy or radiotherapy, according to recent data obtained by Lionel Apetoh and colleague”
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032 · cited 1×
“Cancer-related inflammation and adaptive immunity There is strong evidence from genetic studies of mouse models that cells of the adaptive immune system carry out surveillance and can eliminate nascent tumours (a process called immuno-editing”
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790 · cited 1×
“This transcription factor is constitutively activated both in tumour cells and in immune cells, and is involved in oncogenesis and inhibition of apoptosi”
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695 · cited 1×
“TAMs have been described as “obligate partners for tumour-cell migration, invasion and metastasis&rdquo”
Cited by
Items 501–600 of 1,085
Loges, S., Schmidt, T., & Carmeliet, P. (2010) · Genes & Cancer · doi:10.1177/1947601909356574 · Cited by 257
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis
Del Poggetto, E., Ho, I.-L., Balestrieri, C., Yen, E.-Y., Zhang, S., Citron, F., Shah, R., Corti, D., Diaferia, G. R., Li, C.-Y., et al. (2021) · Science · doi:10.1126/science.abj0486 · Cited by 253
“Many studies have demonstrated that the inflammatory microenvironment can promote tumor growth through the activation of survival and proliferation programs in cancer cells (2, 3).”
BackgroundHwang, I., Kim, J. W., Ylaya, K., Chung, E. J., Kitano, H., Perry, C., Hanaoka, J., Fukuoka, J., Chung, J.-Y., & Hewitt, S. M. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02618-z · Cited by 253
Cannabidiol (CBD) as a Promising Anti-Cancer Drug
Seltzer, E. S., Watters, A. K., MacKenzie, D., Granat, L. M., & Zhang, D. (2020) · Cancers · doi:10.3390/cancers12113203 · Cited by 247
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade
Bonavita, E., Bromley, C. P., Jonsson, G., Pelly, V. S., Sahoo, S., Walwyn-Brown, K., Mensurado, S., Moeini, A., Flanagan, E., Bell, C. R., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.020 · Cited by 248
“Accordingly, inflammatory mediators and signaling pathways commonly found in clinically apparent tumors constitute adverse prognostic factors and promote therapy resistance (Mantovani et al., 2008; Shalapour and Karin, 2019).”
BackgroundSelf-citationThe Role of Inflammation in Lung Cancer
Gomes, M., Teixeira, A. L., Coelho, A., Araújo, A., & Medeiros, R. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-0348-0837-8_1 · Cited by 205
“cancerous tissue often arose at sites of chronic inflammation and that inflammation cells were present in the resect tumors (Bremnes et al. 2011; Mantovani et al. 2008; Balkwill and Mantovani 2001).”
BackgroundHou, P.-P., Luo, L.-J., Chen, H.-Z., Chen, Q.-T., Bian, X.-L., Wu, S.-F., Zhou, J.-X., Zhao, W.-X., Liu, J.-M., Wang, X.-M., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.004 · Cited by 253
Extravillous trophoblast and decidual natural killer cells: a remodelling partnership
Wallace, A. E., Fraser, R., & Cartwright, J. E. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms015 · Cited by 245
“In general, it has been suggested that the macrophages found in tumours are predominantly of a ‘M2’ phenotype, also known as ‘alternatively activated’ and associated with processes such as wound healing, as opposed to pathogen killing and inflammatory cytokine production (Mantovani et al., 2008; Mantovani et al., 2011…”
Cancer and Inflammation: Implications for Pharmacology and Therapeutics
Balkwill, F., & Mantovani, A. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.312 · Cited by 249
Self-citationS1PR1-STAT3 Signaling Is Crucial for Myeloid Cell Colonization at Future Metastatic Sites
Deng, J., Liu, Y., Lee, H., Herrmann, A., Zhang, W., Zhang, C., Shen, S., Priceman, S. J., Kujawski, M., Pal, S. K., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.039 · Cited by 252
Trial watch: Prognostic and predictive value of the immune infiltrate in cancer
Senovilla, L., Vacchelli, E., Galon, J., Adjemian, S., Eggermont, A., Fridman, W. H., Sautès-Fridman, C., Ma, Y., Tartour, E., Zitvogel, L., et al. (2012) · OncoImmunology · doi:10.4161/onci.22009 · Cited by 235
Bellora, F., Castriconi, R., Dondero, A., Reggiardo, G., Moretta, L., Mantovani, A., Moretta, A., & Bottino, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007654108 · Cited by 246
“Accordingly, TAM, frequently characterized by a M2-like polarized phenotype and set in a cancer-promoting mode (17), might also be unable to cooperate with NK cells.”
BackgroundSelf-citationPeriodontal disease and cancer: Epidemiologic studies and possible mechanisms
Nwizu, N., Wactawski‐Wende, J., & Genco, R. J. (2020) · Periodontology 2000 · doi:10.1111/prd.12329 · Cited by 239
The Tumor Microenvironment in Colorectal Carcinogenesis
Peddareddigari, V. G., Wang, D., & DuBois, R. N. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0038-3 · Cited by 237
“TAMs with M2 polarization are a major tumorinfiltrating cell population [3, 47] and are a vital component”
BackgroundManiati, E., Bossard, M., Cook, N., Candido, J. B., Emami-Shahri, N., Nedospasov, S. A., Balkwill, F. R., Tuveson, D. A., & Hagemann, T. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45797 · Cited by 248
Self-citationCancer and the Complement Cascade
Rutkowski, M. J., Sughrue, M. E., Kane, A. J., Mills, S. A., & Parsa, A. T. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0225 · Cited by 250
“Nevertheless, emerging literature examining the mechanistic relationship between inflammation and cancer (4, 9, 10) has almost completely omitted the role of the complement cascade.”
BackgroundShao, Y., Chen, T., Zheng, X., Yang, S., Xu, K., Chen, X., Xu, F., Wang, L., Shen, Y., Wang, T., et al. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy115 · Cited by 242
Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape
Osipov, A., Saung, M. T., Zheng, L., & Murphy, A. G. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0667-0 · Cited by 241
“tion in 1863 of leukocytic infiltration within tumor specimens and his pioneering hypothesis that chronic inflammation has significant implications on tumor growth and survival [30].”
BackgroundTumor stroma: a complexity dictated by the hypoxic tumor microenvironment
Casazza, A., Di Conza, G., Wenes, M., Finisguerra, V, Deschoemaeker, S., & Mazzone, M. (2014) · Oncogene · doi:10.1038/onc.2013.121 · Cited by 243
Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy
Mishra, P., Banerjee, D., & Ben-Baruch, A. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0310182 · Cited by 239
Inflammation, a Double-Edge Sword for Cancer and Other Age-Related Diseases
Gupta, S. C., Kunnumakkara, A. B., Aggarwal, S., & Aggarwal, B. B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02160 · Cited by 243
“The epidemiological, genetic and pharmacological studies support the association of inflammation with chronic diseases (5).”
BackgroundTumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy
Lee, N., Zakka, L. R., Mihm, M. C., & Schatton, T. (2016) · Pathology · doi:10.1016/j.pathol.2015.12.006 · Cited by 250
Koma, Y., Onishi, A., Matsuoka, H., Oda, N., Yokota, N., Matsumoto, Y., Koyama, M., Okada, N., Nakashima, N., Masuya, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080240 · Cited by 250
“Malignant tumors are known to evoke chronic inflammation and malnutrition [13].”
BackgroundA humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer
Bayliss, T. J., Smith, J. T., Schuster, M., Dragnev, K. H., & Rigas, J. R. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.627850 · Cited by 243
“Tumor oncogenes have been linked to cancerrelated inflammation [2].”
BackgroundLaghi, L., Bianchi, P., Miranda, E., Balladore, E., Pacetti, V., Grizzi, F., Allavena, P., Torri, V., Repici, A., Santoro, A., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70186-x · Cited by 251
Self-citationRegulation of macrophage function in tumors: the multifaceted role of NF-κB
Hagemann, T., Biswas, S. K., Lawrence, T., Sica, A., & Lewis, C. E. (2009) · Blood · doi:10.1182/blood-2008-12-172825 · Cited by 248
“which not only trigger pro-survival signals in tumor cells (through NF-κB or STAT3 activation in these cells) but also support their growth and progression.(2,52,57)”
Self-citationWakita, D., Sumida, K., Iwakura, Y., Nishikawa, H., Ohkuri, T., Chamoto, K., Kitamura, H., & Nishimura, T. (2010) · European Journal of Immunology · doi:10.1002/eji.200940157 · Cited by 236
Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions
Adolph, T., Grander, C., Grabherr, F., & Tilg, H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081649 · Cited by 240
“, TNFα or IL-6) are likely candidates to play a role in the chronic inflammatory state which promotes tumor evolution [57,58].”
BackgroundThe influence of diet on anti-cancer immune responsiveness
Soldati, L., Di Renzo, L., Jirillo, E., Ascierto, P. A., Marincola, F. M., & De Lorenzo, A. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1448-0 · Cited by 242
“In fact, TAMs, as well as cancer cells, produce an array of pro-inflammatory cytokines, such as IL-1 beta, TNF-alpha and IL-6 via activation of the transcription factors NF-kB and STAT 3 [25].”
BackgroundTumor-associated macrophages: role in cancer development and therapeutic implications
Salmaninejad, A., Valilou, S. F., Soltani, A., Ahmadi, S., Abarghan, Y. J., Rosengren, R. J., & Sahebkar, A. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00453-z · Cited by 245
Ontogeny of Tumor-Associated Macrophages
Laviron, M., & Boissonnas, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01799 · Cited by 239
“Tumors should be considered as an evolving tissue in which space availability and growth factors expression are changing over time (51, 52) and where inflammatory signals are generated by the loss of tissue integrity and immune cell infiltration (53).”
BackgroundPathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: A review
Sadri Nahand, J., Moghoofei, M., Salmaninejad, A., Bahmanpour, Z., Karimzadeh, M., Nasiri, M., Mirzaei, H. R., Pourhanifeh, M. H., Bokharaei‐Salim, F., Mirzaei, H., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32688 · Cited by 243
Bhat, A. A., Nisar, S., Singh, M., Ashraf, B., Masoodi, T., Prasad, C. P., Sharma, A., Maacha, S., Karedath, T., Hashem, S., et al. (2022) · Cancer Communications · doi:10.1002/cac2.12295 · Cited by 229
“Ulcerative colitis and Crohn’s disease account for 10% to 15% of deaths in patients with CRC [8, 9].”
BackgroundAngiopoietin‐2: a multifaceted cytokine that functions in both angiogenesis and inflammation
Scholz, A., Plate, K. H., & Reiss, Y. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12726 · Cited by 248
Lippitz, B. E., & Harris, R. A. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1093722 · Cited by 248
“inflammatory environment that appears to be a consistent component of malignant tumors.(2,3) The simultaneous cancerinduced activation of the immunosuppressive cytokines IL-10”
BackgroundRediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery
Zelepukin, I. V., Shevchenko, K. G., & Deyev, S. M. (2024) · Nature Communications · doi:10.1038/s41467-024-48838-5 · Cited by 224
Phytochemicals: cancer chemoprevention and suppression of tumor onset and metastasis
Shu, L., Cheung, K.-L., Khor, T. O., Chen, C., & Kong, A.-N. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9239-y · Cited by 245
Wu, J., Li, J., Salcedo, R., Mivechi, N. F., Trinchieri, G., & Horuzsko, A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0938 · Cited by 238
“A connection between inflammation and cancer has been long suspected (1-6).”
Chronic inflammation, cancer development and immunotherapy
Wen, Y., Zhu, Y., Zhang, C., Yang, X., Gao, Y., Li, M., Yang, H., Liu, T., & Tang, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1040163 · Cited by 229
“MYC can directly regulate tissue remodeling, angiogenesis and chronic inflammation to exert oncogenic activity (Mantovani et al., 2008).”
BackgroundPatterson, R. E., Cadmus, L. A., Emond, J. A., & Pierce, J. P. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.01.004 · Cited by 240
“[8] Mantovani A, Allavena P, Sica A, Balkwill F.”
BackgroundBigot, F., Castanon, E., Baldini, C., Hollebecque, A., Carmona, A., Postel-Vinay, S., Angevin, E., Armand, J.-P., Ribrag, V., Aspeslagh, S., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.07.027 · Cited by 235
Generation and Characterization of Murine Alternatively Activated Macrophages
Weisser, S. B., McLarren, K. W., Kuroda, E., & Sly, L. M. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-128-8_14 · Cited by 238
Vanden Berghe, W. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.03.007 · Cited by 243
“Immune cells also infiltrate in tumors, engage in an extensive and dynamic crosstalk with cancer cells [42,81,82].”
BackgroundDual Roles for Immunity in Gastrointestinal Cancers
Ferrone, C., & Dranoff, G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.27.9992 · Cited by 241
“NF- B refers to a family of transcription factors that regulate multiple inflammatory cytokines, adhesion molecules, antiapoptotic proteins, angiogenic factors, and the prostaglandin biosynthetic pathway (through cyclo-oxygenase-2 [COX-2]).(16) NF- B proteins are normally retained in the cytoplasm through a set of inh…”
BackgroundPolish Gastric Cancer Study Group, Sierzega, M., Kolodziejczyk, P., & Kulig, J. (2010) · British Journal of Surgery · doi:10.1002/bjs.7038 · Cited by 246
Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?
Jarnicki, A., Putoczki, T., & Ernst, M. (2010) · Cell Division · doi:10.1186/1747-1028-5-14 · Cited by 240
“In recent years, studies in genetically modified mice have helped to dissect and characterize some of the underlying molecular events that link inflammation to cancer [11,12].”
BackgroundAutophagy in tumorigenesis and energy metabolism: friend by day, foe by night
Mathew, R., & White, E. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.12.008 · Cited by 236
Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma
Kantola, T., Klintrup, K., Väyrynen, J. P., Vornanen, J., Bloigu, R., Karhu, T., Herzig, K.-H., Näpänkangas, J., Mäkelä, J., Karttunen, T. J., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.456 · Cited by 241
“Monocyte chemoattractant MCP-1 has been shown to be overexpressed in several solid tumours, and it is thought to be responsible for acquiring tumour-associated macrophages, which in most tumours present with an antiinflammatory phenotype (Mantovani et al, 2008).”
BackgroundHeparanase: From basic research to therapeutic applications in cancer and inflammation
Vlodavsky, I., Singh, P., Boyango, I., Gutter-Kapon, L., Elkin, M., Sanderson, R. D., & Ilan, N. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.10.001 · Cited by 237
“Chronic inflammatory conditions present in the microenvironment of most tumors (Mantovani et al., 2008) contribute to cancer progression (Grivennikov et al.”
BackgroundInfluentialCentral control of fever and female body temperature by RANKL/RANK
Hanada, R., Leibbrandt, A., Hanada, T., Kitaoka, S., Furuyashiki, T., Fujihara, H., Trichereau, J., Paolino, M., Qadri, F., Plehm, R., et al. (2009) · Nature · doi:10.1038/nature08596 · Cited by 238
Endometriosis-Associated Macrophages: Origin, Phenotype, and Function
Hogg, C., Horne, A. W., & Greaves, E. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00007 · Cited by 238
The Ribosome Biogenesis—Cancer Connection
Penzo, M., Montanaro, L., Treré, D., & Derenzini, M. (2019) · Cells · doi:10.3390/cells8010055 · Cited by 242
Coumarins as privileged scaffold for anti-inflammatory drug development
Grover, J., & Jachak, S. M. (2015) · RSC Advances · doi:10.1039/c5ra05643h · Cited by 233
The association between periodontal disease and cancer: A review of the literature
Fitzpatrick, S. G., & Katz, J. (2010) · Journal of Dentistry · doi:10.1016/j.jdent.2009.10.007 · Cited by 244
Cheng, Y., Dai, J., Sun, C., Liu, R., Zhai, T., Lou, X., & Xia, F. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201712803 · Cited by 241
Ageing: from inflammation to cancer
Leonardi, G. C., Accardi, G., Monastero, R., Nicoletti, F., & Libra, M. (2018) · Immunity & Ageing · doi:10.1186/s12979-017-0112-5 · Cited by 241
“In the nineteenth century Rudolph Virchow was the first to hypothesize a connection between inflammation and cancer, but only in the last two decades researchers have produced striking evidences on the role played by the inflammatory process in promoting cancer [13, 14].”
BackgroundDaurkin, I., Eruslanov, E., Stoffs, T., Perrin, G. Q., Algood, C., Gilbert, S. M., Rosser, C. J., Su, L.-M., Vieweg, J., & Kusmartsev, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1261 · Cited by 235
“flammation (10, 11), frequently caused by aberrant metabolism of arachidonic acid in the tumor microenvironment (12).”
BackgroundDo, H. T. T., Lee, C. H., & Cho, J. (2020) · Cancers · doi:10.3390/cancers12020287 · Cited by 234
“In addition, the movement of different subsets of immune cells into the TME is orchestrated by the chemokine system, followed by the regulation of tumor immune responses in a spatiotemporal manner [2,3], and cancer-related inflammation [4].”
BackgroundThe Role of IL-6 in Cancer Cell Invasiveness and Metastasis—Overview and Therapeutic Opportunities
Rašková, M., Lacina, L., Kejík, Z., Venhauerová, A., Skaličková, M., Kolář, M., Jakubek, M., Rosel, D., Smetana, K., & Brábek, J. (2022) · Cells · doi:10.3390/cells11223698 · Cited by 226
Buric, I., Farias, M., Jong, J., Mee, C., & Brazil, I. A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00670 · Cited by 226
“, depression and posttraumatic stress disorder) (20, 21).”
BackgroundKhosravi, N., Stoner, L., Farajivafa, V., & Hanson, E. D. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.08.187 · Cited by 230
Wang, F., Long, J., Li, L., Wu, Z.-X., Da, T.-T., Wang, X.-Q., Huang, C., Jiang, Y.-H., Yao, X.-Q., Ma, H.-Q., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf5464 · Cited by 222
Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer
Asher, V., Lee, J., Innamaa, A., & Bali, A. (2011) · Clinical and Translational Oncology · doi:10.1007/s12094-011-0687-9 · Cited by 238
“also stimulate angiogenesis and cell proliferation [ 17 ].”
BackgroundMushrooms: A Potential Natural Source of Anti-Inflammatory Compounds for Medical Applications
Elsayed, E. A., El Enshasy, H., Wadaan, M. A. M., & Aziz, R. (2014) · Mediators of Inflammation · doi:10.1155/2014/805841 · Cited by 236
The receptor RAGE: Bridging inflammation and cancer
Riehl, A., Németh, J., Angel, P., & Hess, J. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-12 · Cited by 231
“The generation of the pro-tumourigenic microenvironment strongly depends on the activation of several transcription factors, mainly nuclear factor-κB (NF-κB), signal transducer and activator of transcription 3 (Stat3) and hypoxia-inducible factor-1α (HIF-1α) [4].”
InfluentialTili, E., Michaille, J.-J., Alder, H., Volinia, S., Delmas, D., Latruffe, N., & Croce, C. M. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.003 · Cited by 237
Life history trade-offs in cancer evolution
Aktipis, C. A., Boddy, A. M., Gatenby, R. A., Brown, J. S., & Maley, C. C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3606 · Cited by 235
Chen, P., Huang, Y., Bong, R., Ding, Y., Song, N., Wang, X., Song, X., & Luo, Y. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1354 · Cited by 227
“The link between inflammation and melanoma (35), or hypoxia and melanoma (36) is well established.”
BackgroundThe TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2
Hartwig, T., Montinaro, A., von Karstedt, S., Sevko, A., Surinova, S., Chakravarthy, A., Taraborrelli, L., Draber, P., Lafont, E., Arce Vargas, F., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.01.021 · Cited by 234
“However, although independent studies have associated the secretion of cytokineswith thepotential tomodulate tumor-associated inflammation, neither TRAIL/TRAIL-R nor FADD-mediated signaling in tumor cells has previously been linked with immuno-regulatory roles in cancer (Balkwill and Mantovani, 2012; Mantovani et al.,…”
BackgroundTLR-signaling and proinflammatory cytokines as drivers of tumorigenesis
Korneev, K. V., Atretkhany, K.-S. N., Drutskaya, M. S., Grivennikov, S. I., Kuprash, D. V., & Nedospasov, S. A. (2017) · Cytokine · doi:10.1016/j.cyto.2016.01.021 · Cited by 217
Targeting immune cells for cancer therapy
Gun, S. Y., Lee, S. W. L., Sieow, J. L., & Wong, S. C. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101174 · Cited by 229
Recent advances in active targeting of nanomaterials for anticancer drug delivery
Dutta, B., Barick, K. C., & Hassan, P. A. (2021) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2021.102509 · Cited by 232
Prognostic Significance of Complications after Curative Surgery for Gastric Cancer
Kubota, T., Hiki, N., Sano, T., Nomura, S., Nunobe, S., Kumagai, K., Aikou, S., Watanabe, R., Kosuga, T., & Yamaguchi, T. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3384-9 · Cited by 235
“On the other hand, it is also well established that inflammatory responses to severe postoperative complications are associated with host immunosuppression.(32,33) Consequently, the residual tumor cells may become clinically significant for developing relapse under that circumstance.”
BackgroundNew insights into chronic inflammation-induced immunosuppression
Kanterman, J., Sade-Feldman, M., & Baniyash, M. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.02.008 · Cited by 224
“[84] Mantovani A, Allavena P, Sica A, Balkwill F.”
BackgroundCoulouarn, C., Corlu, A., Glaise, D., Guénon, I., Thorgeirsson, S. S., & Clément, B. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3317 · Cited by 224
“epidemiologic studies suggested that inflammatory diseases predispose individuals to cancer (34).”
BackgroundThe oxysterol–CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils
Raccosta, L., Fontana, R., Maggioni, D., Lanterna, C., Villablanca, E. J., Paniccia, A., Musumeci, A., Chiricozzi, E., Trincavelli, M. L., Daniele, S., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130440 · Cited by 230
“…(Hanahan and Weinberg, 2011) as well as the ability of tumor cells to affect the tumor microenviron ment by smoldering inflammation (de Visser et al., 2006; Mantovani et al., 2008) or even taking advantage of inflammation to grow and metas tasize (Zitvogel et al., 2006; Grivennikov et al., 2010).”
Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis
Li, B., Zhou, P., Liu, Y., Wei, H., Yang, X., Chen, T., & Xiao, J. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.04.023 · Cited by 230
Geng, Y., Shao, Y., Zhu, D., Zheng, X., Zhou, Q., Zhou, W., Ni, X., Wu, C., & Jiang, J. (2016) · Scientific Reports · doi:10.1038/srep39482 · Cited by 233
LI, L. F., CHAN, R. L. Y., LU, L., SHEN, J., ZHANG, L., WU, W. K. K., WANG, L., HU, T., LI, M. X., & CHO, C. H. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1786 · Cited by 224
“IL-1 β has been found to be capable of promoting tumor cells to metastasize, by activating the cancer-related inflammation cascade (102,103).”
Microglia promote colonization of brain tissue by breast cancer cells in a Wnt‐dependent way
Pukrop, T., Dehghani, F., Chuang, H., Lohaus, R., Bayanga, K., Heermann, S., Regen, T., Rossum, D. V., Klemm, F., Schulz, M., et al. (2010) · Glia · doi:10.1002/glia.21022 · Cited by 230
“Additionally, they promote remodeling and neovascularization of the adjacent tissue (Mantovani et al., 2008).”
BackgroundThe role IL-1 in tumor-mediated angiogenesis
Voronov, E., Carmi, Y., & Apte, R. N. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00114 · Cited by 228
“…originates from such myeloid cells and it controls tumor angiogenesis (reviewed in Apte and Voronov, 2008; Murdoch et al., 2008; Coffelt et al., 2010; Ferrara, 2010a; Mantovani and Sica, 2010; Qian and Pollard, 2010; Ruffell et al., 2010; Allavena and Mantovani, 2012; Gabrilovich et al., 2012).”
BackgroundTNF and ubiquitin at the crossroads of gene activation, cell death, inflammation, and cancer
Walczak, H. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01066.x · Cited by 226
“This cancer-related inflammation, apart from promoting the aggressiveness of a cancer, also contributes to tumor immune evasion (21, 22).”
BackgroundMutator activity induced by microRNA-155 ( miR-155 ) links inflammation and cancer
Tili, E., Michaille, J.-J., Wernicke, D., Alder, H., Costinean, S., Volinia, S., & Croce, C. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101795108 · Cited by 227
“Cells were treated overnight with the supernatant of LPSstimulated human THP-1 monocytic cells, namely LPS-stimulated macrophage-conditioned medium (LSMCM), which contains many inflammatory cytokines such as TNF, IL-6, IL-8, and IL1-β (1, 3).”
MethodInsulin resistance and hyperinsulinaemia in the development and progression of cancer
Godsland, I. F. (2010) · Clinical Science · doi:10.1042/cs20090399 · Cited by 231
Zhao, L., Lim, S. Y., Gordon-Weeks, A. N., Tapmeier, T. T., Im, J. H., Cao, Y., Beech, J., Allen, D., Smart, S., & Muschel, R. J. (2013) · Hepatology · doi:10.1002/hep.26094 · Cited by 225
Regulatory T‐cell homeostasis: steady‐state maintenance and modulation during inflammation
Smigiel, K. S., Srivastava, S., Stolley, J. M., & Campbell, D. J. (2014) · Immunological Reviews · doi:10.1111/imr.12170 · Cited by 222
“Several studies now indicate that chronic inflammation can promote cancer by creating a setting in which cell death, necrosis, and mutagenesis are increased (126), and as such, Treg cells may play a protective role in these contexts by dampening inflammationinduced cancer.”
BackgroundWard, J. P., Gubin, M. M., & Schreiber, R. D. (2016) · Advances in Immunology · doi:10.1016/bs.ai.2016.01.001 · Cited by 228
Gondo, T., Nakashima, J., Ohno, Y., Choichiro, O., Horiguchi, Y., Namiki, K., Yoshioka, K., Ohori, M., Hatano, T., & Tachibana, M. (2012) · Urology · doi:10.1016/j.urology.2011.11.070 · Cited by 229
Läubli, H., Pearce, O. M. T., Schwarz, F., Siddiqui, S. S., Deng, L., Stanczak, M. A., Deng, L., Verhagen, A., Secrest, P., Lusk, C., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409580111 · Cited by 228
“Whereas polarization to M1 macrophages enhances tumor cell clearance, polarization to an M2 phenotype supports cancer progression (12, 14).”
BackgroundPurcell, R. V., Pearson, J., Aitchison, A., Dixon, L., Frizelle, F. A., & Keenan, J. I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171602 · Cited by 230
The role of neutrophils in the development of liver diseases
Xu, R., Huang, H., Zhang, Z., & Wang, F.-S. (2014) · Cellular & Molecular Immunology · doi:10.1038/cmi.2014.2 · Cited by 226
The significant role of mast cells in cancer
Khazaie, K., Blatner, N. R., Khan, M. W., Gounari, F., Gounaris, E., Dennis, K., Bonertz, A., Tsai, F.-N., Strouch, M. J., Cheon, E., et al. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9286-z · Cited by 222
A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
Kulbe, H., Chakravarty, P., Leinster, D. A., Charles, K. A., Kwong, J., Thompson, R. G., Coward, J. I., Schioppa, T., Robinson, S. C., Gallagher, W. M., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2178 · Cited by 220
“org Cancer Res; 72(1) January 1, 2012 67”
InfluentialSelf-citationCell membrane-camouflaged nanoparticles as drug carriers for cancer therapy
Xu, C.-H., Ye, P.-J., Zhou, Y.-C., He, D.-X., Wei, H., & Yu, C.-Y. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.01.036 · Cited by 227
Innate Immunity and Cancer Pathophysiology
Maiorino, L., Daßler-Plenker, J., Sun, L., & Egeblad, M. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-032221-115501 · Cited by 215
Immune interactions in endometriosis
Herington, J. L., Bruner-Tran, K. L., Lucas, J. A., & Osteen, K. G. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.53 · Cited by 228
“Additionally, activation of inflammatory responses within the peritoneal cavity may lead to the local production of cytokines and chemokines that enhance the growth of ectopic endometrial tissue by both inhibiting normal apoptotic processes and promoting localized angiogenesis [46,47].”
BackgroundTripathi, C., Tewari, B. N., Kanchan, R. K., Baghel, K. S., Nautiyal, N., Shrivastava, R., Kaur, H., Bhatt, M. L. B., & Bhadauria, S. (2014) · Oncotarget · doi:10.18632/oncotarget.2110 · Cited by 224
Xu, H., Zheng, X., Ai, J., & Yang, L. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109496 · Cited by 205
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Environmental immune disruptors, inflammation and cancer risk
Thompson, P. A., Khatami, M., Baglole, C. J., Sun, J., Harris, S. A., Moon, E.-Y., Al-Mulla, F., Al-Temaimi, R., Brown, D. G., Colacci, A. M., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv038 · Cited by 227
“Over the past two decades, our understanding of inflammation in tumorigenesis has led to the identification of a number of molecules that are strongly linked to the development of human cancers (5,7,8).”
BackgroundInfluential
Metadata
- Authors
- Mantovani, A., Allavena, P., Sica, A., & Balkwill, F.
- Affiliations
- IRCCS Humanitas Research Hospital (IT)
- Fondazione Humanitas per la Ricerca (IT)
- Queen Mary University of London (GB)
- Venue
- Nature
- Published
- 2008-07-01
- Volume
- 454
- Issue
- 7203
- Pages
- 436-444
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2123105952
- Semantic Scholar
- b3a9e344a32ad6ca402d9149ac74b2b1df9e3076
- Cited by
- 11,399
- References
- 175
- Citations by year
- 2026: 419 · 2025: 554 · 2024: 655 · 2023: 761 · 2022: 848 · 2021: 878 · 2020: 864 · 2019: 759 · 2018: 752 · 2017: 732 · 2016: 692 · 2015: 683 · 2014: 643 · 2013: 574 · 2012: 510
- FWCI
- 26.32
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Funders
- Cancer Research UK
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- tumor inflammation, tumor microenvironment, inflammatory mediators, angiogenesis, metastasis, immune evasion, chemoresistance, endocrine response, inflammatory signaling, therapeutic target
- MeSH terms
- Humans, Inflammation, Leukocytes, Neoplasm Invasiveness, Neoplasms, Oncogenes, Gonadal Steroid Hormones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.